The Valley Desk

NCT02912949 · Interventional trial

A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

Overall registry status Active not recruiting

Phase 2

Conditions NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, Solid Tumours Harboring NRG1 Fusion

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov